Pfizer's combination flu and COVID vaccine candidates effective, trial data showsProactive Investors • 10/26/23
Pfizer's combination Covid, flu vaccine will move to final-stage trial after positive dataCNBC • 10/26/23
2 Magnificent Dividend Stocks That Could Deliver a Lifetime of Passive IncomeThe Motley Fool • 10/26/23
Pfizer and BioNTech announce positive data in early trial of flu/COVID combination vaccineMarket Watch • 10/26/23
Pfizer and BioNTech - Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19GlobeNewsWire • 10/26/23
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19Business Wire • 10/26/23
Pfizer's Dividend Yield Is Now 5%. Is the Stock a No-Brainer Buy for Income Investors?The Motley Fool • 10/25/23
A biotech firm founded by Vivek Ramaswamy turned $15 million into $5 billion by flipping a bowel-disease treatment that Pfizer gave it for freeBusiness Insider • 10/24/23
Pfizer's ‘casual' layoffs livestream is the next Better.com CEO gaffe—and workers are lividFast Company • 10/24/23
Pfizer hopes to avoid scaring investors when it reports 3Q results on HalloweenProactive Investors • 10/23/23
Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billionMarket Watch • 10/23/23